Strong H1 for Tissue Science Laboratories with more growth prospects along the way
This article was originally published in Clinica
Executive Summary
Propelled by particularly strong growth in its core markets, Tissue Science Laboratories (TSL) recorded an impressive 82% jump in sales for the first half of 2004, compared with the same period last year. The company posted revenues of £4.0m ($7.2m) for the first six months of this year, and significantly cut its net loss by 71% to £0.5m.